Cite
396P Efficacy and safety of S-1 in elderly patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy: A subgroup analysis of the EAST-LC.
MLA
Yang, J. .. H., et al. “396P Efficacy and Safety of S-1 in Elderly Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC.” Annals of Oncology, vol. 31, Nov. 2020, pp. S1396–97. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.10.390.
APA
Yang, J. .-H., Mok, T. S. K., Lu, S., Nakagawa, K., Yamamoto, N., Shi, Y.-K., Zhang, L., Soo, R. A., Morita, S., & Tamura, T. (2020). 396P Efficacy and safety of S-1 in elderly patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy: A subgroup analysis of the EAST-LC. Annals of Oncology, 31, S1396–S1397. https://doi.org/10.1016/j.annonc.2020.10.390
Chicago
Yang, J.C-H., T.S.K. Mok, S. Lu, K. Nakagawa, N. Yamamoto, Y-K. Shi, L. Zhang, R.A. Soo, S. Morita, and T. Tamura. 2020. “396P Efficacy and Safety of S-1 in Elderly Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC.” Annals of Oncology 31 (November): S1396–97. doi:10.1016/j.annonc.2020.10.390.